Maggie L. Dinome

Maggie L. Dinome

Surgical Oncology
4101 Macon Pond Rd
Raleigh, NC 27607

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.

Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.

Journal: NPJ precision oncology
Published: March 30, 2026

ASO Visual Abstract: Radiation Deescalation in Older Women with Early Stage ER+/HER2- Invasive Breast Cancer.

ASO Visual Abstract: Radiation Deescalation in Older Women with Early Stage ER+/HER2- Invasive Breast Cancer.

Journal: Annals of surgical oncology
Published: January 03, 2026

ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.

ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.

Journal: Annals of surgical oncology
Published: December 04, 2025

Epigenetic programs shaping lung metastasis in triple-negative breast cancer.

Epigenetic programs shaping lung metastasis in triple-negative breast cancer.

Journal: Research square
Published: November 24, 2025

ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.

ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.

Journal: Annals of surgical oncology
Published: October 15, 2025

DNA methylation reprogramming of gene regulatory elements is associated with lung metastasis in triple-negative breast cancer.

DNA methylation reprogramming of gene regulatory elements is associated with lung metastasis in triple-negative breast cancer.

Journal: Communications biology
Published: September 19, 2025

Radiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast Cancer.

Radiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast Cancer.

Journal: Annals of surgical oncology
Published: August 25, 2025

Breast cancer staging for patients with "low-risk" disease: Are they all the same?

Breast cancer staging for patients with "low-risk" disease: Are they all the same?

Journal: Cancer
Published: July 29, 2025

Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.

Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.

Journal: Annals of surgical oncology
Published: July 22, 2025

Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.

Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.

Journal: Annals of surgical oncology
Published: July 14, 2025

ERBB2-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer.

ERBB2-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer.

Journal: JAMA network open
Published: June 11, 2025

Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.

Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.

Journal: Annals of surgical oncology
Published: April 28, 2025
Showing 1-12 of 66

Last Updated: 09/26/2026